Niesje Mennen

Started as a science writer at NRC Handelsblad, covering public health initiatives during the SARS-CoV-2 pandemic. Transitioned to specialized medical journalism at Medisch Contact, reporting on clinical trial developments and Dutch healthcare reforms. Maintains a network of sources across the Radboudumc and Amsterdam UMC hospital systems. Regularly attends Dutch Medical Association conferences to track emerging treatment guidelines. Writes to demystify complex medical developments for a broad professional audience. Focuses on how new therapies integrate into existing care pathways in the Netherlands. Interested in the tension between rapid medical innovation and the slower pace of regulatory approval processes.